TP53BP1 and prostate cancer: This is supported by observations of a delay in resolving γH2AX and 53BP1 foci in TrC1 prostate cancer cells and murine embryonic fibroblasts irradiated at the Bragg peak (31 MeV) compared to those irradiated at the entrance dose (187 MeV) [34].